Arcturus Therapeutics Appoints Steve Hughes, MD, as Chief Development Officer

Retrieved on: 2020-01-07 20:00:00

Tags for this article:

Nucleic acids

Arcturus Therapeutics

Molecular biology

RNA

Biotechnology

Arcturus COVID-19 vaccine

Arcturus Therapeutics Holdings Inc.

Steve Hughes

SAN DIEGO

Click the tags to see associated articles and topics

Arcturus Therapeutics Appoints Steve Hughes, MD, as Chief Development Officer. View article details on hiswai:

Excerpt

<div>... Inc., Takeda Pharmaceutical Company Limited, CureVac AG, <b>Synthetic</b> <b>Genomics</b> Inc. and the Cystic Fibrosis Foundation. For more information visit ...</div>

Article found on:

View Original Article